Review





Similar Products

mv4 11  (ATCC)
99
ATCC mv4 11
Mv4 11, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mv4-11/MV-4-11/pm42955952-452-0-1
Average 99 stars, based on 1 article reviews
mv4 11 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

94
ATCC mv4 11 cells
( A ) Relative cell number of AML cells lines treated with different concentrations of Gwl inhibitor (c604) for 72 h. Cell number is expressed as relative to DMSO treated cells. Values represent mean ± SD of three independent biological replicates. ( B ) Bar plots showing the response to c604 calculated as Area Above the Curve (AAC) from the data presented in ( A ). Bar plots show the mean ± SD ( n = 3 independent biological replicates). ( C ) Gwl genetic dependency of cancer cell lines grouped by primary disease from RNAi Achilles Dataset ( n = 458 cell lines). Statistical significance was calculated by unpaired t test between AML versus the rest of the cancer types (* P < 0.05 , **P < 0.01 and *** P < 0.001). ( D ) Abundance of named proteins across the 14 AML cell lines tested and normalised signal intensity for the phosphorylation of ENSA/ARPP19 at Ser62 and Ser67 obtained from (Gerdes et al,  ) ( n = 3 independent biological replicates from the original dataset). ( E ) Distributions of cell cycle groups (2 N, S, 4 N, 4 N+ and <2 N) in AML cells treated with c604 (0.25 µM) for 24 and 48 h of three independent biological replicates. Statistical significance was calculated by unpaired t test between treated cells versus non-treated (DMSO) groups (* P < 0.05, **P < 0.01 and *** P < 0.001). ( F ) Sequence motifs of significant decreased phosphopeptides in mitotic HeLa cells treated with c604. ( G ) Box plots showing the relative protein abundance of Gwl (MASTL), ENSA, ARPP19, B55α (PPP2R2A), CIP2A, SET and PP2A (PPP2CA) in AML cases and healthy donors (HD). Phosphorylation levels (ppIndex) for ENSA/ARPP19 phosphorylation are also shown. Dots represent individual AML patients or healthy donors (HD). Data from (Casado et al,  ). Unpaired t test was used to calculate the differences between HD and AML groups (* P < 0.05, ** P < 0.01 and *** P < 0.005). (PPP2R2A P = 0.0021; ARPP19 P = 4.6e-07; CIP2A P = 0.93; ENSA P = 1.3e-15; PPP2CA P = 0.033; SET P = 5.3e-07; ARPP19(S62) P = 3.2e-09). Box plots in ( C , D ) show the median (centre), 25th and 75th percentiles (lower and upper bounds of the box), and whiskers extending to the minimum and maximum values within 1.5× the interquartile range.  .
Mv4 11 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mv4-11/Klebsiella+pneumoniae+subsp%2E+pneumoniae+(Schroeter)+Trevisan/pmc13743553-13-0-3
Average 94 stars, based on 1 article reviews
mv4 11 cells - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

99
ATCC human aml cell lines mv4 11
( A ) Relative cell number of AML cells lines treated with different concentrations of Gwl inhibitor (c604) for 72 h. Cell number is expressed as relative to DMSO treated cells. Values represent mean ± SD of three independent biological replicates. ( B ) Bar plots showing the response to c604 calculated as Area Above the Curve (AAC) from the data presented in ( A ). Bar plots show the mean ± SD ( n = 3 independent biological replicates). ( C ) Gwl genetic dependency of cancer cell lines grouped by primary disease from RNAi Achilles Dataset ( n = 458 cell lines). Statistical significance was calculated by unpaired t test between AML versus the rest of the cancer types (* P < 0.05 , **P < 0.01 and *** P < 0.001). ( D ) Abundance of named proteins across the 14 AML cell lines tested and normalised signal intensity for the phosphorylation of ENSA/ARPP19 at Ser62 and Ser67 obtained from (Gerdes et al,  ) ( n = 3 independent biological replicates from the original dataset). ( E ) Distributions of cell cycle groups (2 N, S, 4 N, 4 N+ and <2 N) in AML cells treated with c604 (0.25 µM) for 24 and 48 h of three independent biological replicates. Statistical significance was calculated by unpaired t test between treated cells versus non-treated (DMSO) groups (* P < 0.05, **P < 0.01 and *** P < 0.001). ( F ) Sequence motifs of significant decreased phosphopeptides in mitotic HeLa cells treated with c604. ( G ) Box plots showing the relative protein abundance of Gwl (MASTL), ENSA, ARPP19, B55α (PPP2R2A), CIP2A, SET and PP2A (PPP2CA) in AML cases and healthy donors (HD). Phosphorylation levels (ppIndex) for ENSA/ARPP19 phosphorylation are also shown. Dots represent individual AML patients or healthy donors (HD). Data from (Casado et al,  ). Unpaired t test was used to calculate the differences between HD and AML groups (* P < 0.05, ** P < 0.01 and *** P < 0.005). (PPP2R2A P = 0.0021; ARPP19 P = 4.6e-07; CIP2A P = 0.93; ENSA P = 1.3e-15; PPP2CA P = 0.033; SET P = 5.3e-07; ARPP19(S62) P = 3.2e-09). Box plots in ( C , D ) show the median (centre), 25th and 75th percentiles (lower and upper bounds of the box), and whiskers extending to the minimum and maximum values within 1.5× the interquartile range.  .
Human Aml Cell Lines Mv4 11, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mv4-11/MV-4-11/pm42108312-127-1-10
Average 99 stars, based on 1 article reviews
human aml cell lines mv4 11 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

mv4  (ATCC)
99
ATCC mv4
( A ) Relative cell number of AML cells lines treated with different concentrations of Gwl inhibitor (c604) for 72 h. Cell number is expressed as relative to DMSO treated cells. Values represent mean ± SD of three independent biological replicates. ( B ) Bar plots showing the response to c604 calculated as Area Above the Curve (AAC) from the data presented in ( A ). Bar plots show the mean ± SD ( n = 3 independent biological replicates). ( C ) Gwl genetic dependency of cancer cell lines grouped by primary disease from RNAi Achilles Dataset ( n = 458 cell lines). Statistical significance was calculated by unpaired t test between AML versus the rest of the cancer types (* P < 0.05 , **P < 0.01 and *** P < 0.001). ( D ) Abundance of named proteins across the 14 AML cell lines tested and normalised signal intensity for the phosphorylation of ENSA/ARPP19 at Ser62 and Ser67 obtained from (Gerdes et al,  ) ( n = 3 independent biological replicates from the original dataset). ( E ) Distributions of cell cycle groups (2 N, S, 4 N, 4 N+ and <2 N) in AML cells treated with c604 (0.25 µM) for 24 and 48 h of three independent biological replicates. Statistical significance was calculated by unpaired t test between treated cells versus non-treated (DMSO) groups (* P < 0.05, **P < 0.01 and *** P < 0.001). ( F ) Sequence motifs of significant decreased phosphopeptides in mitotic HeLa cells treated with c604. ( G ) Box plots showing the relative protein abundance of Gwl (MASTL), ENSA, ARPP19, B55α (PPP2R2A), CIP2A, SET and PP2A (PPP2CA) in AML cases and healthy donors (HD). Phosphorylation levels (ppIndex) for ENSA/ARPP19 phosphorylation are also shown. Dots represent individual AML patients or healthy donors (HD). Data from (Casado et al,  ). Unpaired t test was used to calculate the differences between HD and AML groups (* P < 0.05, ** P < 0.01 and *** P < 0.005). (PPP2R2A P = 0.0021; ARPP19 P = 4.6e-07; CIP2A P = 0.93; ENSA P = 1.3e-15; PPP2CA P = 0.033; SET P = 5.3e-07; ARPP19(S62) P = 3.2e-09). Box plots in ( C , D ) show the median (centre), 25th and 75th percentiles (lower and upper bounds of the box), and whiskers extending to the minimum and maximum values within 1.5× the interquartile range.  .
Mv4, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mv4-11/MV-4-11/pm42103719-337-25-26
Average 99 stars, based on 1 article reviews
mv4 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

Image Search Results


( A ) Relative cell number of AML cells lines treated with different concentrations of Gwl inhibitor (c604) for 72 h. Cell number is expressed as relative to DMSO treated cells. Values represent mean ± SD of three independent biological replicates. ( B ) Bar plots showing the response to c604 calculated as Area Above the Curve (AAC) from the data presented in ( A ). Bar plots show the mean ± SD ( n = 3 independent biological replicates). ( C ) Gwl genetic dependency of cancer cell lines grouped by primary disease from RNAi Achilles Dataset ( n = 458 cell lines). Statistical significance was calculated by unpaired t test between AML versus the rest of the cancer types (* P < 0.05 , **P < 0.01 and *** P < 0.001). ( D ) Abundance of named proteins across the 14 AML cell lines tested and normalised signal intensity for the phosphorylation of ENSA/ARPP19 at Ser62 and Ser67 obtained from (Gerdes et al,  ) ( n = 3 independent biological replicates from the original dataset). ( E ) Distributions of cell cycle groups (2 N, S, 4 N, 4 N+ and <2 N) in AML cells treated with c604 (0.25 µM) for 24 and 48 h of three independent biological replicates. Statistical significance was calculated by unpaired t test between treated cells versus non-treated (DMSO) groups (* P < 0.05, **P < 0.01 and *** P < 0.001). ( F ) Sequence motifs of significant decreased phosphopeptides in mitotic HeLa cells treated with c604. ( G ) Box plots showing the relative protein abundance of Gwl (MASTL), ENSA, ARPP19, B55α (PPP2R2A), CIP2A, SET and PP2A (PPP2CA) in AML cases and healthy donors (HD). Phosphorylation levels (ppIndex) for ENSA/ARPP19 phosphorylation are also shown. Dots represent individual AML patients or healthy donors (HD). Data from (Casado et al,  ). Unpaired t test was used to calculate the differences between HD and AML groups (* P < 0.05, ** P < 0.01 and *** P < 0.005). (PPP2R2A P = 0.0021; ARPP19 P = 4.6e-07; CIP2A P = 0.93; ENSA P = 1.3e-15; PPP2CA P = 0.033; SET P = 5.3e-07; ARPP19(S62) P = 3.2e-09). Box plots in ( C , D ) show the median (centre), 25th and 75th percentiles (lower and upper bounds of the box), and whiskers extending to the minimum and maximum values within 1.5× the interquartile range.  .

Journal: EMBO Reports

Article Title: Greatwall kinase regulates acute myeloid leukaemia cell division through a non-canonical mechanism

doi: 10.1038/s44319-026-00955-6

Figure Lengend Snippet: ( A ) Relative cell number of AML cells lines treated with different concentrations of Gwl inhibitor (c604) for 72 h. Cell number is expressed as relative to DMSO treated cells. Values represent mean ± SD of three independent biological replicates. ( B ) Bar plots showing the response to c604 calculated as Area Above the Curve (AAC) from the data presented in ( A ). Bar plots show the mean ± SD ( n = 3 independent biological replicates). ( C ) Gwl genetic dependency of cancer cell lines grouped by primary disease from RNAi Achilles Dataset ( n = 458 cell lines). Statistical significance was calculated by unpaired t test between AML versus the rest of the cancer types (* P < 0.05 , **P < 0.01 and *** P < 0.001). ( D ) Abundance of named proteins across the 14 AML cell lines tested and normalised signal intensity for the phosphorylation of ENSA/ARPP19 at Ser62 and Ser67 obtained from (Gerdes et al, ) ( n = 3 independent biological replicates from the original dataset). ( E ) Distributions of cell cycle groups (2 N, S, 4 N, 4 N+ and <2 N) in AML cells treated with c604 (0.25 µM) for 24 and 48 h of three independent biological replicates. Statistical significance was calculated by unpaired t test between treated cells versus non-treated (DMSO) groups (* P < 0.05, **P < 0.01 and *** P < 0.001). ( F ) Sequence motifs of significant decreased phosphopeptides in mitotic HeLa cells treated with c604. ( G ) Box plots showing the relative protein abundance of Gwl (MASTL), ENSA, ARPP19, B55α (PPP2R2A), CIP2A, SET and PP2A (PPP2CA) in AML cases and healthy donors (HD). Phosphorylation levels (ppIndex) for ENSA/ARPP19 phosphorylation are also shown. Dots represent individual AML patients or healthy donors (HD). Data from (Casado et al, ). Unpaired t test was used to calculate the differences between HD and AML groups (* P < 0.05, ** P < 0.01 and *** P < 0.005). (PPP2R2A P = 0.0021; ARPP19 P = 4.6e-07; CIP2A P = 0.93; ENSA P = 1.3e-15; PPP2CA P = 0.033; SET P = 5.3e-07; ARPP19(S62) P = 3.2e-09). Box plots in ( C , D ) show the median (centre), 25th and 75th percentiles (lower and upper bounds of the box), and whiskers extending to the minimum and maximum values within 1.5× the interquartile range. .

Article Snippet: MV4-11 cells , ATCC , Cat # CRL 9591, RRID: CVCL_0064.

Techniques: Phospho-proteomics, Sequencing, Quantitative Proteomics

( A ) Cell viability of AML cell lines treated with different concentrations of the Gwl inhibitor, compound c604, for 72 h, relative to vehicle-treated cells. Values represent mean ± SD of 3–4 independent biological replicates. ( B ) Response to c604 calculated as Area Above the Curve (AAC) from the data presented in ( A ). ( C ) Gwl genetic dependency of cancer cell lines grouped by primary disease from CRISPR Chronos Dataset ( n = 1094 cell lines). Box plots show the median (centre), 25th and 75th percentiles (lower and upper bounds of the box), and whiskers extending to the minimum and maximum values within 1.5× the interquartile range. Statistical significance was calculated by unpaired t test between AML versus the rest of the cancer types. ( * P < 0.05, ** P < 0.01 and ***P < 0.001) ( P AML vs ATC = 0.05509, BLCA = 0.01087, BALL = 0.02898, CESC = 0.05353, COAD = 0.17415, cSCC = 0.06352, DG = 0.03258, ET = 0.00066, EC = 0.00291, ESCC = 0.08158, EAC = 0.02286, ES = 0.89454, HNSC = 0.00152, LIHC = 0.00098, ICPN = 0.52905, IPNB = 0.00051, BRCA = 0.00086, LPS = 0.10242, LNET = 0.21039, MBCN = 0.01497, MTNKN = 0.16289, MM = 0.01405, MPN = 0.83616, MPNST = 0.19444, NB = 0.03976, NSGCT = 0.24709, NSCLC = 3.8e-05, OM = 0.20201, OS = 0.06286, OV = 0.00042, PAAD = 0.00417, MESO = 0.00357, PRAD = 0.33134, RCC = 0.00479, RC = 0.00371, RMS = 2.4e-05, SS = 0.10010, TALL = 0.65658, UPS = 0.39329). ( D , E ) Relationship between the response calculated for c604 and the protein levels of the named proteins or phosphorylation sites. rho coefficient and statistical significance (by Spearman) are shown. ( F ) Distributions of cell cycle groups (2 N, S, 4 N, 4 N+ and <2 N) in AML cells treated with c604 (2 µM) for 24 and 48 h of three independent biological replicates. Statistical significance was calculated by unpaired t test between treated cells versus non-treated (DMSO) groups (* P < 0.05 , **P < 0.01 and *** P < 0.001). ( G ) Representative Spinning Disk confocal microscopy images of AML cells after 48 h of c604 treatment (2 µM). Nuclei were stained with DAPI (4’,6-diamidino-2-phenylindole, shown in grey scale upper panels) and cells immunostained for β-actin (green). Scale bar: 10 μm. ( H ) The presence of multiple nuclei was analysed after 48 h of c604. Data points show the percentage of binucleated cells (BNC) or multinucleate cells (MNC) over the total of cells analysed for each condition after 48 h of treatment with c604 or DMSO ( n = 260–1919 cells).  .

Journal: EMBO Reports

Article Title: Greatwall kinase regulates acute myeloid leukaemia cell division through a non-canonical mechanism

doi: 10.1038/s44319-026-00955-6

Figure Lengend Snippet: ( A ) Cell viability of AML cell lines treated with different concentrations of the Gwl inhibitor, compound c604, for 72 h, relative to vehicle-treated cells. Values represent mean ± SD of 3–4 independent biological replicates. ( B ) Response to c604 calculated as Area Above the Curve (AAC) from the data presented in ( A ). ( C ) Gwl genetic dependency of cancer cell lines grouped by primary disease from CRISPR Chronos Dataset ( n = 1094 cell lines). Box plots show the median (centre), 25th and 75th percentiles (lower and upper bounds of the box), and whiskers extending to the minimum and maximum values within 1.5× the interquartile range. Statistical significance was calculated by unpaired t test between AML versus the rest of the cancer types. ( * P < 0.05, ** P < 0.01 and ***P < 0.001) ( P AML vs ATC = 0.05509, BLCA = 0.01087, BALL = 0.02898, CESC = 0.05353, COAD = 0.17415, cSCC = 0.06352, DG = 0.03258, ET = 0.00066, EC = 0.00291, ESCC = 0.08158, EAC = 0.02286, ES = 0.89454, HNSC = 0.00152, LIHC = 0.00098, ICPN = 0.52905, IPNB = 0.00051, BRCA = 0.00086, LPS = 0.10242, LNET = 0.21039, MBCN = 0.01497, MTNKN = 0.16289, MM = 0.01405, MPN = 0.83616, MPNST = 0.19444, NB = 0.03976, NSGCT = 0.24709, NSCLC = 3.8e-05, OM = 0.20201, OS = 0.06286, OV = 0.00042, PAAD = 0.00417, MESO = 0.00357, PRAD = 0.33134, RCC = 0.00479, RC = 0.00371, RMS = 2.4e-05, SS = 0.10010, TALL = 0.65658, UPS = 0.39329). ( D , E ) Relationship between the response calculated for c604 and the protein levels of the named proteins or phosphorylation sites. rho coefficient and statistical significance (by Spearman) are shown. ( F ) Distributions of cell cycle groups (2 N, S, 4 N, 4 N+ and <2 N) in AML cells treated with c604 (2 µM) for 24 and 48 h of three independent biological replicates. Statistical significance was calculated by unpaired t test between treated cells versus non-treated (DMSO) groups (* P < 0.05 , **P < 0.01 and *** P < 0.001). ( G ) Representative Spinning Disk confocal microscopy images of AML cells after 48 h of c604 treatment (2 µM). Nuclei were stained with DAPI (4’,6-diamidino-2-phenylindole, shown in grey scale upper panels) and cells immunostained for β-actin (green). Scale bar: 10 μm. ( H ) The presence of multiple nuclei was analysed after 48 h of c604. Data points show the percentage of binucleated cells (BNC) or multinucleate cells (MNC) over the total of cells analysed for each condition after 48 h of treatment with c604 or DMSO ( n = 260–1919 cells). .

Article Snippet: MV4-11 cells , ATCC , Cat # CRL 9591, RRID: CVCL_0064.

Techniques: CRISPR, Phospho-proteomics, Spinning Disk, Confocal, Microscopy, Staining

( A ) Asynchronous AML cells (MV4-11, HL-60 and P31/Fuj cells) were treated with c604 (2 µM) or DMSO for 2 h and then processed for LC-MS/MS based phosphoproteomic analysis ( n = 4 independent biological experiments). ( B ) Number of significant phosphopeptides identified for each cell line compared to DMSO-treated cells (Log2 FC > |0.8 |, P < 0.05 & FDR < 0.15). Statistical differences were assessed using LIMMA. ( C ) Representative phosphopeptides significantly modulated by the treatment in MV4-11 cells linked to FLT3-ITD signalling. ( D ) Normalised signal intensity of the named STAT5 and ERK1 (MAPK3) phosphosites from ( C ). Box plots show the median (centre), 25th and 75th percentiles (lower and upper bounds of the box), and whiskers extending to the minimum and maximum values within 1.5× the interquartile range. ( E ) Representative phosphopeptides significantly modulated by c604 treatment in P31/Fuj cells. .

Journal: EMBO Reports

Article Title: Greatwall kinase regulates acute myeloid leukaemia cell division through a non-canonical mechanism

doi: 10.1038/s44319-026-00955-6

Figure Lengend Snippet: ( A ) Asynchronous AML cells (MV4-11, HL-60 and P31/Fuj cells) were treated with c604 (2 µM) or DMSO for 2 h and then processed for LC-MS/MS based phosphoproteomic analysis ( n = 4 independent biological experiments). ( B ) Number of significant phosphopeptides identified for each cell line compared to DMSO-treated cells (Log2 FC > |0.8 |, P < 0.05 & FDR < 0.15). Statistical differences were assessed using LIMMA. ( C ) Representative phosphopeptides significantly modulated by the treatment in MV4-11 cells linked to FLT3-ITD signalling. ( D ) Normalised signal intensity of the named STAT5 and ERK1 (MAPK3) phosphosites from ( C ). Box plots show the median (centre), 25th and 75th percentiles (lower and upper bounds of the box), and whiskers extending to the minimum and maximum values within 1.5× the interquartile range. ( E ) Representative phosphopeptides significantly modulated by c604 treatment in P31/Fuj cells. .

Article Snippet: MV4-11 cells , ATCC , Cat # CRL 9591, RRID: CVCL_0064.

Techniques: Liquid Chromatography with Mass Spectroscopy, Analysis

( A ) P31/Fuj cells, arrested in mitosis with STLC (5 µM) for 18–20 h, were treated with c604 (2 µM), CDK1 inhibitor, RO-3306 (10 µM) or DMSO and collected for phosphoproteomic analysis ( n = 5 independent biological experiments). Asynchronous P31/Fuj treated with DMSO were also included. HeLa cells arrested in mitosis were included as positive controls. Mitotic cells were collected by mitotic shake off, treated with c604 (2 µM) for 2 h and collected for phosphoproteomic analysis ( n = 5 independent biological experiments). ( B ) Number of phosphopeptides significantly modulated by each condition (Log2 FC > |0.8 |, P < 0.05 and FDR < 0.15). ( C ) FC (expressed in Log2) and FDR values (−Log10 FDR) of ARPP19 (Ser62) and Gwl (Ser875, Ser878) phosphopeptides in the indicated cell lines and treatments. Statistical differences were assessed using LIMMA. ( D , E ) AML cells, RPE1 and HeLa cells, arrested in mitosis using nocodazole (100 ng/ml) or STLC (5 µM) for 18–20 h, were treated with c604 (1-2 µM) for 2 h and processed for western blot analysis. Representative western blot images are shown. ( F , G ) P31/Fuj, HL-60, RPE1 and HeLa cells, arrested in mitosis as before, were treated with CDK1 inhibitor, RO-3306 (10 µM) for 0, 30 and 60 min and collected for western blot analysis. Representative western blot images are shown. ( D – G ) ENSA and pENSA refer to total and phosphorylated ENSA/ARPP19 levels, respectively. Phosphorylation of Histone 3 at Ser10 (pHistone H3 S10) represents a mitotic marker. GAPDH was used as a loading control. For each cell line, identical samples were loaded in duplicate on the same large-format gel because pENSA, total ENSA and pHistone H3 migrate at same molecular weights. After transfer, the membranes were processed separately to enable detection of pENSA and pHistone H3 on one membrane and total ENSA on the corresponding duplicate sample set. All samples originated from the same experiment and were run and processed in parallel. The corresponding loading controls for each membrane are provided in the source data. ( H ) Phosphorylation motifs of identified significantly upregulated (STLC) or downregulated (CDK1i and c604) in P31/Fuj cells. ( I ) Top 10 Gene ontology terms significantly enriched in phosphopeptides significantly upregulated (STLC) or downregulated (CDK1i and c604) in P31/Fuj cells. ( J ) Representative phosphopeptides significantly downregulated by c604 in P31/Fuj cells.  .

Journal: EMBO Reports

Article Title: Greatwall kinase regulates acute myeloid leukaemia cell division through a non-canonical mechanism

doi: 10.1038/s44319-026-00955-6

Figure Lengend Snippet: ( A ) P31/Fuj cells, arrested in mitosis with STLC (5 µM) for 18–20 h, were treated with c604 (2 µM), CDK1 inhibitor, RO-3306 (10 µM) or DMSO and collected for phosphoproteomic analysis ( n = 5 independent biological experiments). Asynchronous P31/Fuj treated with DMSO were also included. HeLa cells arrested in mitosis were included as positive controls. Mitotic cells were collected by mitotic shake off, treated with c604 (2 µM) for 2 h and collected for phosphoproteomic analysis ( n = 5 independent biological experiments). ( B ) Number of phosphopeptides significantly modulated by each condition (Log2 FC > |0.8 |, P < 0.05 and FDR < 0.15). ( C ) FC (expressed in Log2) and FDR values (−Log10 FDR) of ARPP19 (Ser62) and Gwl (Ser875, Ser878) phosphopeptides in the indicated cell lines and treatments. Statistical differences were assessed using LIMMA. ( D , E ) AML cells, RPE1 and HeLa cells, arrested in mitosis using nocodazole (100 ng/ml) or STLC (5 µM) for 18–20 h, were treated with c604 (1-2 µM) for 2 h and processed for western blot analysis. Representative western blot images are shown. ( F , G ) P31/Fuj, HL-60, RPE1 and HeLa cells, arrested in mitosis as before, were treated with CDK1 inhibitor, RO-3306 (10 µM) for 0, 30 and 60 min and collected for western blot analysis. Representative western blot images are shown. ( D – G ) ENSA and pENSA refer to total and phosphorylated ENSA/ARPP19 levels, respectively. Phosphorylation of Histone 3 at Ser10 (pHistone H3 S10) represents a mitotic marker. GAPDH was used as a loading control. For each cell line, identical samples were loaded in duplicate on the same large-format gel because pENSA, total ENSA and pHistone H3 migrate at same molecular weights. After transfer, the membranes were processed separately to enable detection of pENSA and pHistone H3 on one membrane and total ENSA on the corresponding duplicate sample set. All samples originated from the same experiment and were run and processed in parallel. The corresponding loading controls for each membrane are provided in the source data. ( H ) Phosphorylation motifs of identified significantly upregulated (STLC) or downregulated (CDK1i and c604) in P31/Fuj cells. ( I ) Top 10 Gene ontology terms significantly enriched in phosphopeptides significantly upregulated (STLC) or downregulated (CDK1i and c604) in P31/Fuj cells. ( J ) Representative phosphopeptides significantly downregulated by c604 in P31/Fuj cells. .

Article Snippet: MV4-11 cells , ATCC , Cat # CRL 9591, RRID: CVCL_0064.

Techniques: Analysis, Western Blot, Phospho-proteomics, Marker, Control, Membrane, Liquid Chromatography with Mass Spectroscopy

Reagents and tools table

Journal: EMBO Reports

Article Title: Greatwall kinase regulates acute myeloid leukaemia cell division through a non-canonical mechanism

doi: 10.1038/s44319-026-00955-6

Figure Lengend Snippet: Reagents and tools table

Article Snippet: MV4-11 cells , ATCC , Cat # CRL 9591, RRID: CVCL_0064.

Techniques: